Trial pipeline
Track psilocybin trial phases, recruitment, sponsors and registry completion dates with country filters, source links, comparison and free data exports.
Free access · No subscription for research tools or data exports
Filter the development pipeline
7 trials match this view; 9 reported facilities; 9 have usable coordinates. Latest indexed registry check Nov 19, 2026 02:23 UTC. Country membership uses reported locations, including locations without coordinates; Mapped-facility counts cover all sites of matching trials, including international sites, and require valid coordinates.
Enrollment sum: 207 across 7 records with a reported count. Planned and actual counts are mixed; this is not a count of unique treated participants.
Recorded study-start years
Current indexed registry status
Reported research conditions
Counts describe indexed registry records, not efficacy or total research activity. A trial can count under several conditions or countries. Unknown dates are excluded from the start-year chart; future years reflect planned starts. Stopped studies may reflect recruitment, funding or strategy and are not automatically treatment failures.
Milestones to investigate
The table is ordered by reported primary completion date. Check whether the registry calls enrollment estimated or actual, when the record was last updated, and whether results have been published. Completion dates are not readout dates; no model-generated success probabilities are assigned.
For late-stage studies, choose PHASE3 above. For studies still underway, choose an exact recruitment status. Use sponsor and country filters to inspect a programme, then save records to compare their designs.
Matching trial records
| Trial | Sponsor and phase | Status | Enrollment | Start / primary completion / completion | Research workflow |
|---|---|---|---|---|---|
| Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress DisorderTreatment Resistant Disorders · Post Traumatic Stress Disorder | Halucenex Life Sciences Inc. PHASE2 | Unknown status Registry updated 2023-06-29 | 20 ESTIMATED | 2022-10-03 2023-10-30 2023-12-30 | |
| A Randomized, Placebo-controlled Trial of Psychedelic-assisted Psychotherapy With Single Dose Psilocybin for Frontline Clinicians Experiencing COVID-related Symptoms of Depression and BurnoutBurnout, Caregiver · Burnout, Professional · COVID-19 · Depression · Post Traumatic Stress Disorder · Moral Injury | University of Washington PHASE3 | Completed Registry updated 2025-03-18 | 30 ACTUAL | 2022-03-03 2023-12-30 2024-06-30 | |
| The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress DisorderPost Traumatic Stress Disorder | COMPASS Pathways PHASE2 | Completed Registry updated 2025-06-13 | 22 ACTUAL | 2022-06-10 2024-02-12 2024-02-12 | |
| Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and EfficacyPost Traumatic Stress Disorder | Johns Hopkins University PHASE1 | Active, not recruiting Registry updated 2026-06-22 | 20 ESTIMATED | 2024-06-07 2026-03-09 2027-05 | |
| A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)Post Traumatic Stress Disorder · PTSD | Sunstone Medical PHASE2 | Recruiting Registry updated 2026-07-01 | 70 ESTIMATED | 2026-05-23 2027-11 2028-05 | |
| Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label TrialPost Traumatic Stress Disorder · PTSD · Chronic PTSD | Unity Health Toronto PHASE2 | Active, not recruiting Registry updated 2026-10-06 | 15 ESTIMATED | 2026-06-01 2028-01 2028-06 | |
| A Pilot Mechanistic RCT of Psilocybin With Mindfulness-based Therapy vs Support for Posttraumatic Stress Disorder (PTSD)Post Traumatic Stress Disorder · Depression - Major Depressive Disorder | Anthony P King PHASE2 | Recruiting Registry updated 2026-10-19 | 30 ESTIMATED | 2026-09-01 2029-09 2029-12 |
Reported research facilities
Halucenex Life Sciences Inc.Windsor, Nova Scotia, Canada · Coordinates available
St. Michael's Hospital, Unity Health TorontoToronto, Ontario, Canada · Coordinates available
Kings College London, Institute of Psychiatry, Psychology and NeurologyLondon, United Kingdom · Coordinates available
Icahn School of Medicine at Mount SinaiNew York, New York, United States · Coordinates available
Johns Hopkins Center for Psychedelic and Consciousness ResearchBaltimore, Maryland, United States · Coordinates available
Sunstone Medical, PCRockville, Maryland, United States · Coordinates available
Sunstone TherapiesRockville, Maryland, United States · Coordinates available
The Ohio State University Medical CenterColumbus, Ohio, United States · Coordinates available
University of WashingtonSeattle, Washington, United States · Coordinates available
This directory includes reported facilities with and without coordinates. For a country-filtered view, locations are labeled as selected-country sites or international sites of matching trials. Facilities are registry-reported trial sites, not an independently verified clinic or research-centre directory. Current services and contact details must be checked at the source.